Published in Diabetologia on July 20, 2011
Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk. Atherosclerosis (2015) 1.46
Impact of type 2 diabetes mellitus and glucose control on fractional flow reserve measurements in intermediate grade coronary lesions. Clin Res Cardiol (2013) 0.85
HbA₁c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients. Cardiovasc Diabetol (2013) 0.84
PLA1A2 platelet polymorphism predicts mortality in prediabetic subjects of the population based KORA S4-Cohort. Cardiovasc Diabetol (2014) 0.82
Performance of HbA1c and fasting plasma glucose in screening for diabetes in patients undergoing coronary angiography. Diabetes Care (2012) 0.78
The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin. PLoS One (2015) 0.75
Oral glucose tolerance test in patients with undiagnosed diabetes and coronary artery disease: when should it be performed? Diabetologia (2012) 0.75
45(th) Annual Meeting of International Society for Pediatric Neurosurgery, Denver, USA, 8-12 October, 2017. Childs Nerv Syst (2017) 0.75
[Outpatient rehabilitation after myocardial infarction or for heart failure]. Herz (2012) 0.75
Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia (2005) 5.47
Endonuclease IV (nfo) mutant of Escherichia coli. J Bacteriol (1986) 5.32
Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond) (2006) 3.69
Hypoglycemic symptoms and frequency of severe hypoglycemia in patients treated with human and animal insulin preparations. Diabetes Care (1991) 3.51
Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet (1993) 3.34
A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes]. Dtsch Med Wochenschr (2007) 2.67
Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans. J Clin Microbiol (1992) 2.27
First-time use of newer oral contraceptives and the risk of venous thromboembolism. Contraception (1997) 2.27
Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes. Proc Natl Acad Sci U S A (1991) 2.21
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res (2010) 1.99
A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2. Cell Mol Life Sci (2006) 1.92
C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors. J Neurosci (2001) 1.90
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial. Gene Ther (2008) 1.88
Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart (2003) 1.86
Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system. Diabetes Care (2001) 1.79
Home Use of an Artificial Beta Cell in Type 1 Diabetes. N Engl J Med (2015) 1.75
Reovirus: viral therapy for cancer 'as nature intended'. Clin Oncol (R Coll Radiol) (2008) 1.74
Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci U S A (1990) 1.67
Insulin glulisine: a faster onset of action compared with insulin lispro. Diabetes Obes Metab (2007) 1.67
A novel insulin formulation with a more rapid onset of action. Diabetologia (2008) 1.57
Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. J Clin Invest (1999) 1.53
Papillary muscle shortening for mitral valve reconstruction in patients with ischaemic mitral insufficiency. Eur Heart J (1998) 1.50
Individual rate constants for the interaction of Ras proteins with GTPase-activating proteins determined by fluorescence spectroscopy. Biochemistry (1997) 1.49
Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham Heart Study. Int J Obes (Lond) (2010) 1.49
DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours. Eur J Endocrinol (2011) 1.48
Wound therapy with autologous bone marrow stem cells in diabetic patients with ischaemia-induced tissue ulcers affecting the lower limbs. Int J Clin Pract (2007) 1.46
Continuous glucose monitoring: quality of hypoglycaemia detection. Diabetes Obes Metab (2012) 1.45
No evidence for accumulation of insulin glargine (LANTUS): a multiple injection study in patients with Type 1 diabetes. Diabet Med (2002) 1.42
Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J (2003) 1.41
Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J (2012) 1.40
[The hyperventilation syndrome]. Dtsch Med Wochenschr (1995) 1.39
Air bubbles in insulin pens. Lancet (1989) 1.39
[Hypothenar hammer syndrome as a cause of severe digital ischemia]. Dtsch Med Wochenschr (2004) 1.38
Author reply to Reiger et. al. commentary on Genetic variation of the platelet- surface integrin GPIIb-IIIa (PIA1/A2-SNP) shows a high association with Type 2 diabetes mellitus.Diabetologia. 2003 Jul;46(7):984-9. Diabetologia (2004) 1.38
Reversible cognitive deterioration after a single episode of severe hypoglycaemia: a case report. Diabet Med (2004) 1.38
The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia (2012) 1.38
Anaphylactoid reactions after indocyanine-green administration. Ann Intern Med (1988) 1.35
Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT--initial experience. Radiology (1999) 1.32
Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin. Diabetes Obes Metab (2009) 1.26
Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects. Diabetologia (1994) 1.25
Sensors for glucose monitoring: technical and clinical aspects. Diabetes Metab Res Rev (2001) 1.24
Prevalence of renal artery stenosis in diabetes mellitus--an autopsy study. J Intern Med (1991) 1.24
Assembly in an in vitro splicing reaction of a mouse insulin messenger RNA precursor into a 60-40S ribonucleoprotein complex. Nucleic Acids Res (1986) 1.23
Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue. Int J Obes (Lond) (2009) 1.23
Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med (2005) 1.21
Injection-meal interval: recommendations of diabetologists and how patients handle it. Diabetes Res Clin Pract (1999) 1.20
A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet (2000) 1.19
Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery. Exp Clin Endocrinol Diabetes (2002) 1.18
Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol (2008) 1.17
First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system. Biosens Bioelectron (2003) 1.15
Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging. J Magn Reson Imaging (1999) 1.14
PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS) Eur Heart J (1996) 1.12
Smoking is associated with progression of diabetic nephropathy. Diabetes Care (1994) 1.11
Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus. Diabet Med (2004) 1.09
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism. Hum Reprod (2000) 1.06
Community-based stroke incidence trends from the 1970s through the 1980s in East Germany. Stroke (1995) 1.05
Genetic relatedness of Cryptococcus neoformans clinical isolates grouped with the repetitive DNA probe CNRE-1. J Clin Microbiol (1995) 1.05
Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. J Investig Allergol Clin Immunol (2009) 1.05
Association of glucose levels and glucose variability with mood in type 1 diabetic patients. Diabetologia (2007) 1.04
Glucose monitoring by microdialysis: performance in a multicentre study. Diabet Med (2009) 1.04
Insulin aspart in a 30/70 premixed formulation. Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture. Diabetes Care (1997) 1.01
Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin. Diabetes Care (1998) 1.01
Nutritional behaviour differences in Germany. Rev Environ Health (1996) 0.98
Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients. Diabetes Care (2001) 0.98
Intraoperative microwave ablation for curative treatment of atrial fibrillation in open heart surgery--the MICRO-STAF and MICRO-PASS pilot trial. MICROwave Application in Surgical treatment of Atrial Fibrillation. MICROwave Application for the Treatment of Atrial Fibrillation in Bypass-Surgery. Thorac Cardiovasc Surg (1999) 0.98
Quality indicators for the prevention of type 2 diabetes in Europe--IMAGE. Horm Metab Res (2010) 0.97
Microdialysis-based 48-hour continuous glucose monitoring with GlucoDay: clinical performance and patients' acceptance. Diabetes Technol Ther (2006) 0.97
Flow velocity of single lymphatic capillaries in human skin. Am J Physiol (1996) 0.97
Isolation and characterization of human monoclonal antibodies against hepatitis C virus envelope glycoproteins. J Med Virol (1998) 0.97
Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women. Diabetes Care (1992) 0.96
Near-normotension and near-normoglycemia in blind type I diabetic patients with overt diabetic nephropathy. J Diabet Complications (1991) 0.96
Time-action profile of insulin detemir and NPH insulin in patients with type 2 diabetes from different ethnic groups. Diabetes Obes Metab (2006) 0.95
Traffic hypoglycaemias and accidents in patients with diabetes mellitus treated with different antidiabetic regimens. J Intern Med (2002) 0.95
Detection of inflamed atherosclerotic lesions with diadenosine-5',5'''-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography. Proc Natl Acad Sci U S A (2006) 0.95
Bacterial biofilm within diseased pancreatic and biliary tracts. Gut (2005) 0.95
Rapid and long-acting analogues as an approach to improve insulin therapy: an evidence-based medicine assessment. Curr Pharm Des (2001) 0.95
Correlation between blood glucose concentration in diabetics and noninvasively measured tissue optical scattering coefficient. Opt Lett (1997) 0.93
Chromium in metabolic and cardiovascular disease. Horm Metab Res (2007) 0.93
Inactivation of the fis gene leads to reduced growth rate. FEMS Microbiol Lett (1992) 0.93
Reliability of vertebral fracture assessment using multidetector CT lateral scout views: the Framingham Osteoporosis Study. Osteoporos Int (2010) 0.93
A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy. Diabet Med (2013) 0.92
Angina intensity is not different in diabetic and non-diabetic patients with acute myocardial infarction. Z Kardiol (2003) 0.92
HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm Metab Res (2003) 0.92
A model for studying the distortion of muscle oxygen uptake patterns by circulation parameters. Eur J Appl Physiol Occup Physiol (1991) 0.92
Postural effect on cardiac output, oxygen uptake and lactate during cycle exercise of varying intensity. Eur J Appl Physiol Occup Physiol (1994) 0.92
Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients. Int J Clin Pract (2012) 0.91
Drotrecogin alfa (activated) inhibits NF-kappa B activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis. Inflamm Res (2004) 0.91
Non-invasive glucose monitoring in patients with diabetes: a novel system based on impedance spectroscopy. Biosens Bioelectron (2006) 0.90
Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome. Cancer (1997) 0.90
Sonographic and clinical pattern of extracranial and cranial giant cell arteritis. Scand J Rheumatol (2012) 0.89
A new therapeutic approach to popliteal artery entrapment syndrome (PAES). Eur J Vasc Endovasc Surg (1995) 0.89
Experimental and theoretical evidence supporting the role of Gly363 in blood coagulation factor IXa (Gly193 in chymotrypsin) for proper activation of the proenzyme. J Biol Chem (1990) 0.89
Quantitative gene expression analysis of fractalkine using laser microdissection in biopsies from kidney allografts with acute rejection. Transplant Proc (2004) 0.89